Feature Channels: Drugs and Drug Abuse

Filters close
Released: 29-Nov-2023 4:05 PM EST
Substance abuse treatment helps reduce reported methamphetamine use among men who have sex with men
University of California, Los Angeles (UCLA), Health Sciences

A nearly decade-long study by UCLA researchers found that substance abuse treatment of any kind may help to reduce methamphetamine usage among men who have sex with other men.

Released: 29-Nov-2023 12:05 PM EST
Workplace culture is very different these days. Find out how different by exploring the "In the Workplace" channel
Newswise

The latest articles on occupational medicine, workplace culture, and the labor market are in the "In the Workplace" channel on Newswise.

       
Released: 28-Nov-2023 7:00 AM EST
Mount Sinai Creates Research Center Focusing on Opioids, Emerging Substances, and Drug Overdose
Mount Sinai Health System

Center aims to transform treatment and care for patients in Emergency Departments across the United States

Released: 22-Nov-2023 8:05 AM EST
Digital payment platforms can easily be misused for drug dealing
University of California, Davis

Digital payment platforms such as Venmo work great for sharing a dinner bill with friends, buying gifts at a pop-up shop or making payments without cash or credit cards.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Released: 20-Nov-2023 7:05 PM EST
Genomic study links cannabis abuse to multiple health problems
Yale University

A Yale-led analysis of the genomes of more than 1 million people has shed light on the underlying biology of cannabis use disorder and its links to psychiatric disorders, abuse of other substances such as tobacco, and possibly even an elevated risk of developing lung cancer.

Not for public release

This news release is embargoed until 20-Nov-2023 5:00 PM EST Released to reporters: 14-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 20-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 20-Nov-2023 12:05 PM EST
Tiny traps can provide new knowledge about difficult-to-treat diseases
Chalmers University of Technology

Researchers at Chalmers University of Technology have developed a new method to capture many proteins in nano-sized traps. This method can be used to study the formation of protein clumps, which are linked to many diseases.

Newswise: First human clinical trial for pill-sized device that monitors breathing from the gut
Released: 18-Nov-2023 1:05 PM EST
First human clinical trial for pill-sized device that monitors breathing from the gut
Cell Press

Scientists have developed an ingestible device that can safely monitor vital signs like breathing and heart rate from inside humans. The tool, described November 17 in the journal Device, has the potential to provide accessible and convenient care for people at risk of opioid overdose.

Released: 17-Nov-2023 1:05 PM EST
Environment and wallet benefit from redispensing cancer pills
Radboud University Medical Centre Nijmegen

Redispensing cancer drugs reduces both environmental impact and medical costs, according to research from Radboudumc pharmacy published in JAMA Oncology. The annual savings could amount to tens of millions.

Newswise:Video Embedded from-tobacco-to-alcohol-to-opioids-sanford-burnham-prebys-researchers-are-pursuing-novel-leads-and-promising-therapies-to-treat-addiction
VIDEO
Released: 16-Nov-2023 3:05 PM EST
From tobacco to alcohol to opioids, Sanford Burnham Prebys researchers are pursuing novel leads and promising therapies to treat addiction
Sanford Burnham Prebys

Tens of millions of Americans are addicted to illicit drugs, alcohol, tobacco and other substances including opioids, with both immediate and long-term harm to not just themselves, but also family, friends and society.

Released: 15-Nov-2023 11:20 AM EST
From Farm to Newsroom: The Latest Research and Features on Agriculture
Newswise

The world’s total population is expected to reach 9.9 billion by 2050. This rapid increase in population is boosting the demand for agriculture to cater for the increased demand. Below are some of the latest research and features on agriculture and farming in the Agriculture channel on Newswise.

Newswise: FDA approval for Zepbound: FSU researcher available for context on newly approved weight loss treatment
Released: 14-Nov-2023 3:05 PM EST
FDA approval for Zepbound: FSU researcher available for context on newly approved weight loss treatment
Florida State University

By: Bill Wellock | Published: November 14, 2023 | 2:43 pm | SHARE: The U.S. Food and Drug Administration recently approved the medication Zepbound for weight management treatment.Tirzepatide, the active ingredient in the Eli Lilly and Company’s trademarked Zepbound, was already approved to help improve blood sugar (glucose) in adults with type 2 diabetes mellitus.

Newswise: IU awarded $5 million grant to find ways to transform adolescent opioid use disorder care in Indiana
Released: 14-Nov-2023 10:05 AM EST
IU awarded $5 million grant to find ways to transform adolescent opioid use disorder care in Indiana
Indiana University

IU School of Medicine researchers are taking steps to improve the accessibility and quality of care for adolescents experiencing opioid use disorder (OUD) and other substance use disorders (SUDs), thanks to a new $5 million grant from the National Institute of Health's Helping to End Addiction Long-Term (HEAL) Initiative.

Released: 14-Nov-2023 8:00 AM EST
States With Legalized Medical Marijuana See Decline in Nonmedical Opioid Use
Institute for Health, Health Care Policy and Aging Research at Rutgers University

Researchers found that when states implement medical cannabis laws, there is a 0.5 to 1.5 percentage point decrease in regular to frequent (up to or greater than once per week on average) nonmedical prescription opioid use among people who reported using opioids in the previous year.

Released: 11-Nov-2023 1:05 PM EST
Almost half of people who use drugs in rural areas were recently incarcerated
Oregon Health & Science University

New research finds that almost half of people who use illicit drugs in rural areas have been recently incarcerated.

   
Released: 8-Nov-2023 1:30 PM EST
Conceptual model identifies factors to mitigate risk for opioid misuse during cancer care
Wolters Kluwer Health: Lippincott

Among cancer patients, psychological distress and accessibility of opioids often lead to chemical coping, a middle ground between addiction and proper adherence to a medication regimen.

Newswise: Stigma felt by opioid-dependent moms impacts the health care received by their babies
Released: 1-Nov-2023 5:05 PM EDT
Stigma felt by opioid-dependent moms impacts the health care received by their babies
University of Missouri, Columbia

The rate of opioid use among pregnant women in the United States quadrupled between 1999 and 2014 and continues to rise — an alarming trend that researchers from the University of Missouri and University of Iowa say has exposed the stigma felt by opioid-dependent mothers and how their shame has negatively impacted the health care received by their infants.

Newswise: UK researchers awarded $2.6 million to study new drug combination driving overdose deaths
Released: 1-Nov-2023 1:05 PM EDT
UK researchers awarded $2.6 million to study new drug combination driving overdose deaths
University of Kentucky

Cassandra Gipson-Reichardt, Ph.D., and Terry Hinds, Jr., Ph.D., associate professors in the University of Kentucky College of Medicine’s Department of Pharmacology and Nutritional Sciences, have received a $2.65 million five-year grant from the National Institute on Drug Abuse (NIDA) to support research to understand how xylazine and fentanyl change the brain’s signaling pathways.

Released: 25-Oct-2023 5:00 PM EDT
AANA Updates, Publishes Analgesia and Anesthesia Practice Considerations for The Substance Use Disorder Patient
American Association of Nurse Anesthesiology

To help ensure that patients with active substance use disorder, on medication-assisted treatment, or in abstinent recovery continue to receive high-quality, safe pain management and anesthesia care, the American Association of Nurse Anesthesiology (AANA) has published its updated analgesia and anesthesia practice considerations.

Newswise: Study Suggests Marijuana Use Damages Brain Immune Cells Vital to Adolescent Development
Released: 25-Oct-2023 12:05 PM EDT
Study Suggests Marijuana Use Damages Brain Immune Cells Vital to Adolescent Development
Johns Hopkins Medicine

In a mouse study designed to explore the impact of marijuana’s major psychoactive compound, THC, on teenage brains, Johns Hopkins Medicine researchers say they found changes to the structure of microglia, which are specialized brain immune cells, that may worsen a genetic predisposition to schizophrenia. The

Released: 25-Oct-2023 11:05 AM EDT
Amid Cocaine Addiction, the Brain Struggles to Evaluate Which Behaviors Will Be Rewarding
Rutgers University-New Brunswick

Rutgers researchers find long-term users of cocaine may continue with unrewarding behavior because of changes in brain structure and chemistry responsible for generating an important teaching signal.

Newswise: Dysregulation of the Brain’s Reward Learning System Is Identified by Scientists as a Potential Driver and Treatment Target for Cocaine Addiction
24-Oct-2023 11:40 AM EDT
Dysregulation of the Brain’s Reward Learning System Is Identified by Scientists as a Potential Driver and Treatment Target for Cocaine Addiction
Mount Sinai Health System

A Mount Sinai-led team of researchers has shed new light on the ways in which cocaine addiction dysregulates the normal function of dopamine neurons and thus the brain’s ability to process and respond to reward-related information, making it more difficult for individuals to change their addictive behaviors.

Not for public release

This news release is embargoed until 23-Oct-2023 5:00 PM EDT Released to reporters: 17-Oct-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Oct-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 19-Oct-2023 2:05 PM EDT
UC Irvine study reveals surge in use of weight loss-linked drugs in California health system
University of California, Irvine

In a first-of-its-kind study, researchers from the University of California, Irvine have discovered an extraordinary surge in the utilization of weight loss-associated GLP-1 receptor agonists, a class of medications commonly used in the treatment of Type 2 diabetes and obesity, that is poised to accelerate, based on emerging clinical evidence.

Newswise: URI, UMass Chan Medical School researchers developing high-tech armband to help people with opioid-use disorder
Released: 19-Oct-2023 12:05 PM EDT
URI, UMass Chan Medical School researchers developing high-tech armband to help people with opioid-use disorder
University of Rhode Island

The opioid epidemic has continued unabated since its start in the 1990s. According to the Centers for Disease Control and Prevention, nearly 280,000 people in the U.S, died from overdoses involving prescription opioids from 1999 to 2021.

Newswise: 25 years of Herceptin: A groundbreaking advancement in breast cancer treatment
Released: 19-Oct-2023 11:05 AM EDT
25 years of Herceptin: A groundbreaking advancement in breast cancer treatment
University of California, Los Angeles (UCLA), Health Sciences

Herceptin has saved millions of women’s lives by targeting cancer at its genetic roots. In this interview, Dr. Slamon talks about the paradigm-shifting approach to cancer treatment and how the discovery has opened up an entirely new area of research.

Released: 17-Oct-2023 1:05 PM EDT
Rockland Launches Novel Analytical Tools to Assess Drug Delivery: Revolutionizing Oligonucleotide Therapeutic Development
Rockland Immunochemicals, Inc

The first and only panel of specialty reagents designed to detect PS modifications independent of sequence, format, or location, streamlining candidate triage for unparalleled cost and time savings in non-clinical/pre-clinical discovery assessment of oligonucleotide drug candidates, clinical trials for immunogenicity studies, and other applications.

Released: 17-Oct-2023 11:05 AM EDT
MDMA increases feelings of connection during conversation, showing promise for therapy
University of Chicago Medical Center

New research shows that both MDMA and methamphetamine deepened personal connections after guided conversations, suggesting different mechanisms for how these drugs produce feelings of closeness.

13-Oct-2023 11:55 PM EDT
Recovery Checkups in Primary Care Settings Linked to Increased Substance Use Treatment and Reduced Alcohol and Cannabis Use in Patients with Complex Needs
Research Society on Alcoholism

Highly vulnerable patients with alcohol use disorder (AUD) or substance use disorder (SUD) who received regular assessments after their initial intervention had substantially better outcomes a year later than those who did not receive the same follow-up, according to a new study. Fewer than one in ten people with SUD receive any form of treatment in a given year; among those who do, relapse and treatment reentry are common. A Screening, Brief Intervention, and Referral to Treatment (SBIRT) protocol is intended to facilitate treatment referrals, especially among patients with more severe SUDs, but research has shown it to be relatively ineffective in that regard. Adding a Recovery Management Checkup (RMC) intervention can improve treatment rates; RMC conceptualizes AUD and SUD as chronic conditions requiring longer-term monitoring via regular check-ins, early re-intervention in cases of relapse, and treatment retention strategies. For the study in Alcohol: Clinical & Experimental Resear

     

Not for public release

This news release is embargoed until 16-Oct-2023 5:00 PM EDT Released to reporters: 10-Oct-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-Oct-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

9-Oct-2023 4:10 PM EDT
Opioid use disorder treatment associated with decreased risk of overdose after surgery, suggests first-of-its-kind study of over 4 million surgeries
American Society of Anesthesiologists (ASA)

Although people with opioid use disorder (OUD) are significantly more likely to overdose or have a complication after major surgery than those without the disorder, using medications for the treatment of OUD before surgery may eliminate that extra risk, suggests a large, first-of-its-kind study presented at the ANESTHESIOLOGY® 2023 annual meeting.

Released: 13-Oct-2023 6:05 PM EDT
Targeting a coronavirus ion channel could yield new Covid-19 drugs
Massachusetts Institute of Technology (MIT)

Chemists discover the structures of open and closed states of the channel, which could help the development of antiviral drugs to reduce inflammation

11-Oct-2023 1:05 PM EDT
Opioid limits didn’t change surgery patients’ experience, study shows
Michigan Medicine - University of Michigan

Worries that surgery patients would have a tougher recovery if their doctors had to abide by a five-day limit on opioid pain medication prescriptions didn’t play out as expected, a new study finds. Instead, patient-reported pain levels and satisfaction didn’t change at all for Michigan adults who had their appendix or gallbladder removed, a hernia repaired, a hysterectomy or other common operations after the state’s largest insurer put the limit in place, the study shows.

Newswise: UK awarded $3.4 million to lead equity initiative in drug abuse research
Released: 13-Oct-2023 9:10 AM EDT
UK awarded $3.4 million to lead equity initiative in drug abuse research
University of Kentucky

The University of Kentucky has been selected as the nationwide coordination center for a National Institutes of Health (NIH) initiative. Danelle Stevens-Watkins, Ph.D., will lead the National Institute on Drug Abuse (NIDA) Racial Equity Initiative as principal investigator.

Released: 11-Oct-2023 8:05 AM EDT
Five years of legal cannabis in Canada: mixed success
Canadian Medical Association (CMA)

Five years after cannabis legalization in Canada, it appears to be a mixed success, with social justice benefits outweighing health benefits, write authors in a commentary published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.230808.

Not for public release

This news release is embargoed until 9-Oct-2023 5:00 PM EDT Released to reporters: 3-Oct-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 9-Oct-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 9-Oct-2023 1:05 PM EDT
Prescription opioid companies increased marketing after Purdue Pharma lawsuit, UW study shows
University of Washington

Public scrutiny of Purdue Pharma’s role in the opioid crisis increased sharply in the years after the state of Kentucky filed a lawsuit against the company. New research from David Tan, University of Washington associate professor of management, examines the ensuing behavior of competing prescription opioid companies.

Released: 9-Oct-2023 6:50 AM EDT
Factors associated with marijuana use among high-risk college students
Texas A&M University

The past decade has seen a significant increase in marijuana use among U.S. college students. This increase has coincided with notable changes in national and local cannabis laws and policies, and perceptions of the associated drug’s risk over the same period.

Newswise: Cellular Atlas of Amygdala Reveals New Treatment Target for Cocaine Addiction
Released: 5-Oct-2023 11:50 AM EDT
Cellular Atlas of Amygdala Reveals New Treatment Target for Cocaine Addiction
University of California San Diego

Researchers at University of California San Diego School of Medicine have used single-cell sequencing to identify a potential new treatment for cocaine addiction and shed new light on the molecular underpinnings of addiction.

Released: 5-Oct-2023 10:40 AM EDT
NIH Awards Wake Forest University School of Medicine $10 Million to Study Long-term Opioid Use, Chronic Pain
Wake Forest University School of Medicine

Researchers at Wake Forest University School of Medicine have received a five-year $10 million grant from the National Institute on Drug Abuse, part of the National Institutes of Health (NIH), to create a broad research program that will work to reduce opioid-related harms and improve quality of life in patients on long-term opioid therapy.

Released: 5-Oct-2023 10:30 AM EDT
Rutgers Helps Document How Surge of Cheap, Flavored Cigars Targets Young Consumers
Rutgers University-New Brunswick

A report from the university’s Institute for Nicotine and Tobacco Studies and the Campaign for Tobacco-Free Kids shows how companies have flooded the market with products that appeal to young people.

   
Released: 5-Oct-2023 8:00 AM EDT
Psychedelics improve mental health, cognition in special ops veterans
Ohio State University

One treatment each of two psychedelic drugs lowered depression and anxiety and improved cognitive functioning in a sample of U.S. special operations forces veterans who sought care at a clinic in Mexico, according to a new analysis of the participants’ charts.

Released: 2-Oct-2023 11:00 AM EDT
New research indicates some people may be physically unable to use police breathalysers
University of Sheffield

Some people may be physically unable to use the current evidential breath analysis machines, relied upon by police to gather proof of driving under the influence of alcohol or drugs, new research from the University of Sheffield indicates.

   
Released: 29-Sep-2023 4:05 AM EDT
Cannabis use disorder may be linked to increased risk of cardiovascular disease
Society for the Study of Addiction

A new study has found that Canadian adults with cannabis use disorder appear to have an approximately 60% higher risk of experiencing their first heart attack, stroke, or other major cardiovascular event than those without cannabis use disorder.

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Released: 26-Sep-2023 3:05 PM EDT
Elevated temperatures and climate change may contribute to rising drug and alcohol disorders
Columbia University, Mailman School of Public Health

Hospital visits from alcohol- and substance-related disorders are driven by elevated temperatures and could be further affected by rising temperatures due to climate change, according to new research by environmental health scientists at Columbia University Mailman School of Public Health.

Released: 20-Sep-2023 10:05 AM EDT
Safer Neighborhoods May Mitigate Risk of Child Abuse
Rutgers University-New Brunswick

Improving the built environment and expanding housing services in low-incoming communities are protective factors against child abuse, Rutgers study finds.

Newswise: The Medical Minute: Stay positive when talking with people with substance use disorders
Released: 20-Sep-2023 10:05 AM EDT
The Medical Minute: Stay positive when talking with people with substance use disorders
Penn State Health

A conversation can be the catalyst for someone struggling with addiction to get the care they need. But tread carefully. Two Penn State Health experts discuss a difficult conversation.



close
1.38677